Skip to content
Pill with imprint G 1911, orange, oval, 11 mm (Rimantadine Hydrochloride 100 mg)

“Rimantadine Hydrochloride Tablets, 100 mg-Each orange, oval, film-coated, convex-faced tablet is debossed with a "G" on one side and "1911" on the other side”

G 1911 pill

Pill with imprint G 1911 is orange, oval, 11 mm and has been identified as Rimantadine Hydrochloride 100 mg. It is used for flu. It is supplied by Physician Therapeutics LLC.

Rimantadine Hydrochloride 100 mg

Imprint
G 1911
Strength
100 mg
Used for
Flu
Color
Orange
Shape
Oval
Size
11 mm
Score
No score line
Form
Tablet
Manufacturer
Physician Therapeutics LLC
Drug class
Influenza a m2 protein inhibitor
NDC
68405-110, 68405-110-26, 52959-305, 0115-1911, 52959-305-30, 16590-202, 16590-202-14, 68151-2103, 68151-2103-0, 0115-1911-01, 0115-1911-02

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked . Photo: Amneal Pharmaceuticals.

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Rimantadine Hydrochloride pills and guides

What is Rimantadine Hydrochloride used for?

Rimantadine Hydrochloride is used for flu.

Medicine type
Influenza a m2 protein inhibitor
Official uses from the US prescribing label

Rimantadine hydrochloride tablet is indicated for the prophylaxis and treatment of illness caused by various strains of influenza A virus in adults (17 years and older).

Rimantadine hydrochloride tablet is indicated for prophylaxis against influenza A virus in children (1 year to 16 years of age).

Prophylaxis

In controlled studies of children (1 year to 16 years of age), healthy adults (17 years and older), and elderly patients (65 years of age and older), rimantadine hydrochloride has been shown to be safe and effective in preventing signs and symptoms of infection caused by various strains of influenza A virus. Since rimantadine hydrochloride does not completely prevent the host immune response to influenza A infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically-related viruses. Following vaccination during an influenza outbreak, rimantadine hydrochloride prophylaxis should be considered for the 2 to 4 week time period required to develop an antibody response. However, the safety and effectiveness of rimantadine hydrochloride prophylaxis have not been demonstrated for longer than 6 weeks.

Treatment

Rimantadine hydrochloride therapy should be considered for adults (17 years and older) who develop an influenza-like illness during known or suspected influenza A infection in the community. When administered within 48 hours after onset of signs and symptoms of infection caused by influenza A virus strains, rimantadine hydrochloride has been shown to reduce the duration of fever and systemic symptoms.

The following points should be considered before initiating treatment or prophylaxis with rimantadine hydrochloride:

  • Rimantadine hydrochloride is not a substitute for early vaccination on an annual basis as recommended by the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices.
  • Influenza viruses change over time. Emergence of resistance mutations could decrease drug effectiveness. Other factors (for example, changes in viral virulence) might also diminish clinical benefit of antiviral drugs. Prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use rimantadine hydrochloride.

From the FDA-approved label on DailyMed (published Jan 01, 2024).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows G and the other side shows 1911.
  • It is orange, oval, 11 mm.
  • The score line, coating and any logo match the photo.
  • It came from a pharmacy package that names the same drug.

One of the pills in the Rimantalist pack.

Ingredients

Active: Rimantadine Hydrochloride

Inactive: Magnesium Stearate, Cellulose, Microcrystalline, Water, Fd&c Yellow No. 6, Hypromelloses, Polyethylene Glycol

Also distributed by

H.j. Harkins Company, Inc., Stat Rx USA LLC, Carilion Materials Management, Amneal Pharmaceuticals of New York LLC

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.